FDA moves to ban phenylephrine, found in dozens of popular cold medications, after research shows it performs no better than ...

Biopharmas and global agencies are now prioritizing initiatives and innovations to drive speed across product development ...

HHS secretary Robert F. Kennedy Jr. has been on the receiving end of two heated letters from lawmakers outlining the threats ...

The Food and Drug Administration granted fast track designation to AUTX-703 for relapsed or refractory acute myelogenous ...

A New Drug Application has been accepted seeking accelerated approval for dordaviprone for patients with recurrent H3 ...

An update to the FDA drug shortage list on Feb. 21 listed the ... executive vice president of U.S. operations and global business development and president of Novo Nordisk, said in the release.

More on semaglutide compounds:Shortage of popular drugs Wegovy and Ozempic is over, FDA says. Americans who ... For Hims and other compounders, this development starts the clock on having ...